Aller au contenu principal
CAS 0 fiche

CAS 10191-41-0

Le CAS 10191-41-0 correspond à 0 fiche d’annexe de l’UE dans les annexes II à VI du règlement (CE) n° 1223/2009.

Fiches pour le CAS 10191-41-0

0 au total
Aucune fiche trouvée pour ce numéro CAS.

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 10191-41-0
CAS 10191-41-0PubChem CID 2116

DL-alpha-Tocopherol

2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-ol is a tocopherol. — ChEBI

Nom IUPAC
2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-ol
Formule moléculaire
C29H50O2
Masse moléculaire
430.7 g/mol
Masse exacte
430.381080833 Da
XLogP3
10,7
Surface polaire topologique
29,5 Ų
Donneurs de liaisons hydrogène
1
Accepteurs de liaisons hydrogène
2
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

Ephanylalpha-Tocopherol, DL-Vitamin E DL-alphadl-.alpha.-TocopherolUNII-7QWA1RIO01DL-5,7,8-trimethyltocol7QWA1RIO01CCRIS 5853
16 autres noms signalés
2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-EINECS 233-466-0.Alpha.-tocopherol, DL-RONOTEC DF 120IRGANOX E 210UVINUL 2000AOBRN 0094012J24.789HINS NO.307CRAC-.ALPHA.-TOCOPHEROLINS-307CHSDB 8261EC 233-466-06-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-5-17-04-00168 (Beilstein Handbook Reference)DL-.ALPHA.-TOCOPHEROL [MI]
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:22470

α-tocopherol

A tocopherol that is chroman-6-ol substituted by methyl groups at positions 2, 5, 7 and 8 and a 4,8,12-trimethyltridecyl group at position 2.

Formule
C29H50O2
Masse moyenne
430.707 g/mol
Masse monoisotopique
430.38108 Da
Charge formelle
0
  • tocopherol — is a (CHEBI:27013)
  • vitamin E — is a (CHEBI:33234)
  • plant metabolite — has role (CHEBI:76924)
  • food antioxidant — has role (CHEBI:77962)
  • plant metabolite — has role (CHEBI:76924)
  • food antioxidant — has role (CHEBI:77962)
  • tocopherol — is a (CHEBI:27013)
  • vitamin E — is a (CHEBI:33234)
Noms supplémentaires validés
rel-(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol2,5,7,8-tetramethyl-2-(4',8',12'-trimethyltridecyl)-6-chromanol(+-)-alpha-tocopherolE 307E-307E307all-rac-alpha-tocopheroldl-alpha-tocopherol
Références croisées de cette source

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2023-05-31. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant2116

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 25.2% (567 of 2247) of reports. Source: European Chemicals Agency (ECHA)
  • Signal: Warning Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H317 (74.3%): May cause an allergic skin reaction [Warning Sensitization, Skin] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 2247 reports by companies from 11 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 567 of 2247 reports by companies.; There are 10 notifications provided by 1680 of 2247 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Toxicity Summary: IDENTIFICATION AND USE: dl-alpha-Tocopherol is a slightly viscous, pale yellow oil. This is a synthetic form of alpha tocopherol. The activity of natural alpha-tocopherol on an equal weight basis, is at least twice as high as the synthetic form. dl-alpha-Tocopherol is used as an antioxidant in fats and oils and in animal feed. It is also used as experimental medication and as a dietary supplement. HUMAN EXPOSURE AND TOXICITY: Of 23,908 patients patch tested, 219 (0.9%) had sunscreen coded as an allergen source. The top 3 most frequent allergens in sunscreens were benzophenone-3, dl-alpha-tocopherol, and fragrance mix. Dietary supplementation with moderate dosage synthetic dl-alpha-tocopherol acetate did not significantly prolong bleeding or platelet aggregation in healthy volunteers. dl-alpha-Tocopherol provided protection against exercise-induced oxidative injury in healthy volunteers according to several reports. In vitro experiments demonstrated general inhibition of cell proliferation by dl-alpha-tocopherol, with breast and prostate cancer cells distinctly more sensitive than erythroleukemia cells. ANIMAL STUDIES: In chicks exposed to dl-alpha-tocopherol acetate for 3-8 weeks i Source: Hazardous Substances Data Bank (HSDB)
  • Toxicity Summary: Although all forms of Vitamin E exhibit antioxidant activity, it is known that the antioxidant activity of vitamin E is not sufficient to explain the vitamin's biological activity. Vitamin E's anti-atherogenic activity involves the inhibition of the oxidation of LDL and the accumulation of oxLDL in the arterial wall. It also appears to reduce oxLDL-induced apoptosis in human endothelial cells. Oxidation of LDL is a key early step in atherogenesis as it triggers a number of events which lead to the formation of atherosclerotic plaque. In addition, vitamin E inhibits protein kinase C (PKC) activity. PKC plays a role in smooth muscle cell proliferation, and, thus, the inhibition of PKC results in inhibition of smooth muscle cell proliferation, which is involved in atherogenesis. Vitamin E's antithrombotic and anticoagulant activities involves the downregulation of the expression of intracellular cell adhesion molecule(ICAM)-1 and vascular cell adhesion molecule(VCAM)-1 which lowers the adhesion of blood components to the endothelium. In addition, vitamin E upregulates the expression of cytosolic phospholipase A2 and cyclooxygenase (COX)-1 which in turn enhances the release of prostacy Source: Toxin and Toxin Target Database (T3DB)
  • Environmental Bioconcentration: An estimated BCF of 39 was calculated in fish for dl-alpha-tocopherol(SRC), using an estimated log Kow of 12.2(1) and a regression-derived equation(1). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is moderate(SRC), provided the compound is not metabolized by the organism(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 2.5X10+7(SRC), determined from a structure estimation method(2), indicates that dl-alpha-tocopherol is expected to be immobile in soil(SRC). Volatilization of dl-alpha-tocopherol from moist soil surfaces is expected to be an important fate process(SRC) given an estimated Henry's Law constant of 7.9X10-5 atm-cu m/mole(SRC), using a fragment constant estimation method(2). However, adsorption to soil is expected to attenuate volatilization(SRC). dl-alpha-Tocopherol is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 1.4X10-8 mm Hg at 25 °C(SRC), determined from a fragment constant method(2). Naturally occurring alpha-tocopherol was biodegraded by aerobic bacterial communities isolated from marine sediment(3). However, biodegradation data on dl-alpha-tocopherol relevant to environmental importance in soil were not available.(SRC, 2015). dl-alpha-Tocopherol has a UV absorption maxima at 294 nm(4) and, therefore, may be susceptible to direct photolysis on soil surfaces exposed to sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 2.5X10+7(SRC), determined from a structure estimation method(2), indicates that dl-alpha-tocopherol is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 7.9X10-5 atm-cu m/mole(SRC), developed using a fragment constant estimation method(2). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 29 hours and 15 days, respectively(SRC). However, volatilization from water surfaces is expected to be attenuated by adsorption to suspended solids and sediment in the water column(SRC). The estimated volatilization half-life from a model pond is >10 years if adsorption is considered(4). According to a classification scheme(5), an estimated BCF of 39(SRC), from an estimated log Kow of 12.2(2) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is moderate(SRC). Naturally occurring alpha-tocopherol was biodegraded by aerobic bacterial communities isolated from marine sediment(5). However, biodegr Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), dl-alpha-tocopherol, which has an estimated vapor pressure of 1.4X10-8 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist in both the vapor and particulate phases (in the ambient atmosphere. Vapor-phase dl-alpha-tocopherol is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 1.7 hours(SRC), calculated from its rate constant of 1.7X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(2). Particulate-phase dl-alpha-tocopherol may be removed from the air by wet and dry deposition(SRC). dl-alpha-Tocopherol has a UV absorption maxima at 294 nm(3), and therefore, may be susceptible to direct photolysis by sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Sources/Uses: The natural form of vitamin E found in green vegetables, grains, and oils; Used in antioxidants and as a vitamin E supplement; [Merck Index] Used as an antioxidant and nutritional additive in animals feeds; [ExPub: EFSA] Permitted for use as an inert ingredient in non-food pesticide products; [EPA] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Farming (Feed Additives) [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: MEDICATION Source: Hazardous Substances Data Bank (HSDB)
  • Uses: All-rac-alpha-tocopherol is mainly used as an antioxidant in fats and oils and in feedingstuffs rich in oils and fats. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: There are several forms of vitamin E available commercially /including dl-alpha-tocopherol/. These are available as nutritional supplements or in functional and fortified foods. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Laboratory chemicals; manufacture of substances Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Vitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps. Source: Toxin and Toxin Target Database (T3DB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Comment le CAS 10191-41-0 est utilisé sur ce site

Le CAS 10191-41-0 est l’identifiant du Chemical Abstracts Service utilisé pour rattacher cette page à une substance précise. Dans le jeu de données actuel, 0 fiche d’annexe de l’UE partage cet identifiant, ce qui vous aide à vérifier si la même substance apparaît dans un seul contexte réglementaire ou dans plusieurs.

Utilisez cette page lorsqu’une spécification fournisseur, une FDS ou un dossier de matière première vous donne le CAS 10191-41-0 et que vous devez voir au même endroit toutes les fiches liées des annexes II à VI. Les cartes d’entrées ci-dessus sont le moyen le plus rapide d’accéder aux limites de concentration, aux avertissements, à l’annexe concernée et aux conditions par type de produit.